Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Expedite Drug Development With An Integrated CDMO-CRO Model
From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
Helping Biotechs Overcome 4 Key Challenges
Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.
Why Life Science Organizations Need A Chief Patient Officer Function
Bridging the gap between innovation and impact, this exploration of the Chief Patient Officer role offers a strategic framework to integrate patient insights and de-risk the product lifecycle.
Participants Don't Care How Your Vendor Stack Works
Participants experience one study, not the vendor stack behind it. Learn how sponsors and CROs can reduce burden with support built around real study needs.

Running Flexible Trials In The Heart Of Patient Communities
5/14/2025

Bringing clinical research closer to patients by running flexible trials in the heart of their own communities increases access to research for both patients and sites.
ICH E6(R3) Annex 2: Navigating GCP Requirements For Decentralized Trials
7/24/2026

Implementing decentralized components or real-world data requires proactive alignment with updated GCP standards for data access, remote consent, and multi-stream investigator oversight.
The Evolution Of GLP-1s: Overcoming Clinical Development Challenges
7/23/2026

Explore clinical development trends, recruitment hurdles, study design strategies, and emerging therapies shaping obesity and metabolic disease research.
Inspection Facilitation Without Local MAH Presence
5/26/2026

Local expertise and centralized oversight ensured compliant, well‑coordinated inspections across countries, reducing operational risk and client burden while maintaining consistent authority engagement.
Change Needed In Approach To Clinical Trials Patient Recruitment
8/20/2026

Drawing on real-world experience and end-to-end capabilities, this presentation outlines actionable strategies to accelerate recruitment, boost predictability, and expand patient trial access.

Advancing Analgesic Development With Validated Pain Models

Explore validated pain models and integrated early-phase services designed to characterize dose response, evaluate safety and efficacy, and support informed decisions in analgesic development.
Ergomed's Patient-Centric Focus Drives Our Team

Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.
Patient Recruitment With A Patient-Centric Approach

At Avance Clinical, patients are our priority. We meticulously select experienced sites and clinics, alongside patient advocacy groups and communities to ensure optimal patient care and outcomes.
Decentralized Trials Support: Direct-To-Patient Supply Management

Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.
High-Content Flow Cytometry

Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.